Tamotsu Takamatsu

This inventor holds 10 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignee: Toyama Chemical Co., Ltd.. Active years: 2002-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamotsu Takamatsu. Retrieved from https://idiyas.com/inventor/tamotsu-takamatsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 70.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 24(Granted Patents)

Company Filing History:

10 out of 159

Toyama Chemical Co., Ltd.

patents

Years Active: 2002-2012

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE43676 - Alkyl ether derivatives or salts thereof (2012-09-17),

2. 8168789 - Organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile and method for producing the same (2012-05-01),

3. 8153816 - Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-OXO-2-substituted-2,3-dihydro-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process (2012-04-10),

4. 8129535 - Alkyl ether derivatives or salts thereof (2012-03-06),

5. 8017789 - Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-OXO-2-substituted-2,3-dihydro-1,2-benzisoxazol-6-yl]methoxy]phenyl]proprionate ester and intermediate for the process (2011-09-13),

6. 7468443 - Alkyl ether derivatives or salts thereof (2008-12-23),

7. 7371868 - Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate, as well as salt of 7-isoindoline-quinolonecarboxylic acid derivative, its hydrate and composition comprising the same as active ingredient (2008-05-13),

8. 7087594 - Alkyl ether derivatives or salts thereof (2006-08-08),

9. 6482835 - PROCESSES FOR PRODUCING 7-ISOINDOLINE-QUINOLONECARBOXYLIC ACID DERIVATIVE AND ITS INTERMEDIATE, AS WELL AS SALT OF 7-ISOINDOLINE-QUINOLONECARBOXYLIC ACID DERIVATIVE, ITS HYDRATE AND COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT (2002-11-19),

10. 6337399 - Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and composition containing the same as active ingredient (2002-01-08),

Title: The Innovative Contributions of Tamotsu Takamatsu

Introduction: Tamotsu Takamatsu, a distinguished inventor based in Toyama, Japan, has made significant strides in the field of chemical innovations. With a total of 10 patents to his name, Takamatsu has contributed to advancements that hold great promise for therapeutic applications, particularly in the realm of neuronal health.

Latest Patents: Among his latest contributions, Takamatsu developed an innovative compound of alkyl ether derivatives or salts thereof. This specific compound exhibits remarkable activity in protecting neurons, accelerating nerve regeneration, and promoting neurite extension, making it an invaluable therapeutic agent for various central and peripheral nerve diseases. Additionally, he holds a patent for an organic amine salt of 6-fluoro-3-hydroxy-2-pyrazinecarbonitrile and its production method. This compound is noteworthy for its excellent crystallinity and is considered a promising production intermediate for creating 6-fluoro-3-hydroxy-2-pyrazinecarboxamide.

Career Highlights: Tamotsu Takamatsu is currently associated with Toyama Chemical Co., Ltd., where he continues to embark on groundbreaking projects. His expertise and innovative mindset have established him as a pivotal figure in the research and development sector within his company.

Collaborations: Throughout his career, Takamatsu has collaborated with esteemed colleagues such as Kenji Yonezawa and Akihito Saitoh. Together, these inventors form a dynamic team that fosters creativity and innovation, further enhancing their contributions to the field.

Conclusion: Tamotsu Takamatsu's inventive spirit and dedication to research have undoubtedly left a significant mark on the world of chemical innovation. His patents not only exemplify his expertise but also hold the potential to address critical health challenges related to nerve diseases. As he continues his work at Toyama Chemical Co., Ltd., the future promises even more groundbreaking advancements from this remarkable inventor.

Profile summary based on public USPTO records.